Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)

Part of paid clinical trials in Philadelphia, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT06963463
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • TranS-C — BEHAVIORAL
    This intervention includes participants attending 6-8 sessions with a Sleep Therapist.
  • Sleep Feedback — BEHAVIORAL
    Participants are provided with an actigraphy watch that is used to monitor their sleep and activity throughout the day and complete a sleep diary daily. Along with wearing the watch they also will be provided access to their actigraphy and sleep diary graphs that document their data.

Study Details

The goal of this clinical trial is to adapt a sleep intervention for individuals representative of all demographic groups, including those who are at the highest risk for suicidal behavior. Sleep difficulties are a promising target for youth with suicidal thoughts and behavior to focus on as a prevention measure. We aim to increase intervention acceptability and impact by adapting it for the adolescent populations at highest risk for suicidal thoughts and behavior. The research project will compare Transdiagnostic Sleep and Circadian Intervention (TranS-C), an evidence based, modularized intervention that targets a range of sleep difficulties to a treatment as usual or control condition including providing weekly sleep feedback reports from data entered into a daily sleep diary and from wearing a sleep sensing, actigraphy watch. Participants in both conditions (TranS-C vs. Sleep Feedback) will wear an actigraphy sleep watch that monitors sleep, and complete daily sleep diaries via smartphone or email. Participants in the TranS-C condition will also wear bright light (BL) and blue blocking glasses each day as well as attend weekly or biweekly sessions with a Sleep Therapist. The sleep therapist will review sleep feedback during sessions.

Key Dates

Start date
May 6, 2025
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
Jul 31, 2027

Study Design

Enrollment
90 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Sleep Feedback
    Participants receive an actigraphy watch to track their sleep and activity levels and complete a daily sleep diary; sleep feedback graphs show participants their actigraphy watch and sleep diary data on demand.
  • Experimental: TranS-C + Sleep Feedback
    Participants will attend 6-8 TranS-C sessions with a Sleep therapist. Participants will also wear bright light glasses in the morning and blue light blocking glasses in the evening throughout the intervention.

Primary Outcome Measure

Feasibility-Attendance [ Time Frame: From enrollment to the end of the treatment (up to 4 months) ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Childrens Hospital of PhiladelphiaPhiladelphiaPennsylvania19104
Jami Young, PhD
[email protected]
215-590-7555
University of PittsburghPittsburghPennsylvania15213
Tina Goldstein
[email protected]
412-246-5604

Find similar trials in Philadelphia, PA

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Childrens Hospital of Philadelphia· Philadelphia, PAUniversity of Pittsburgh· Pittsburgh, PA

Related Studies